Catalyst Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Catalyst Capital Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.3K	Buy	+468	New	+$39.2K	﹤0.01%	302
2026 Q1	–	Sell	-1,011	Closed	-$86.2K	–	382
2025 Q4	$86.2K	Sell	1,011 -292	-22%	-$24K	﹤0.01%	285
2025 Q3	$101K	Sell	1,303 -57	-4%	-$4.45K	﹤0.01%	313
2025 Q2	$106K	Buy	+1,360	New	+$101K	﹤0.01%	326
2025 Q1	–	Sell	-726	Closed	-$53.7K	–	473
2024 Q4	$53.7K	Buy	+726	New	+$50.8K	﹤0.01%	377
2018 Q4	–	Sell	-1,725	Closed	-$100K	–	437
2018 Q3	$100K	Sell	1,725 -300	-15%	-$14.7K	﹤0.01%	265
2018 Q2	$98K	Sell	2,025 -58,425	-97%	-$2.73M	﹤0.01%	273
2018 Q1	$2.81M	Sell	60,450 -20,700	-26%	-$899K	0.1%	107
2017 Q4	$3.05M	Buy	81,150 +6,150	+8%	+$226K	0.11%	103
2017 Q3	$2.73M	Buy	75,000 +44,400	+145%	+$1.69M	0.12%	112
2017 Q2	$1.21M	Buy	+30,600	New	+$1.12M	0.05%	165
2016 Q3	–	Sell	-30,000	Closed	-$997K	–	468
2016 Q2	$997K	Buy	+30,000	New	+$1.03M	0.18%	136
2015 Q4	–	Sell	-8,478	Closed	-$220K	–	575
2015 Q3	$201K	Sell	8,478 -2,394	-22%	-$57.8K	0.03%	269
2015 Q2	$258K	Sell	10,872 -12	-0.1%	-$271	0.03%	291
2015 Q1	$258K	Sell	10,884 -3,966	-27%	-$89K	0.03%	264
2014 Q4	$315K	Buy	14,850 +3,438	+30%	+$69.1K	0.04%	276
2014 Q3	$194K	Buy	+11,412	New	+$180K	0.03%	296
2013 Q4	–	Sell	-102,540	Closed	-$1.19M	–	270
2013 Q3	$1.19M	Buy	102,540 +54,588	+114%	+$639K	0.65%	42
2013 Q2	$537K	Buy	+47,952	New	+$568K	0.42%	92

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Catalyst Capital Advisors's EW Position: Q2 2026 in Review

Catalyst Capital Advisors opened a new position in Edwards Lifesciences (EW) in Q2 2026: 468 shares worth $42.3K. The stake represents ﹤0.01% of the portfolio and ranks #302 among its holdings. This is a return to the name: Catalyst Capital Advisors previously reported a position in EW as recently as Q4 2025.

Catalyst Capital Advisors first reported a position in EW in Q2 2013 and has held it in 19 quarters since. The position peaked at $3.05M in Q4 2017. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Catalyst Capital Advisors held 468 shares of Edwards Lifesciences worth $42.3K as of Q2 2026.
Edwards Lifesciences was a new Catalyst Capital Advisors position in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of Catalyst Capital Advisors's portfolio in Q2 2026, its #302 holding.
Catalyst Capital Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 19 quarters since.
Catalyst Capital Advisors's Edwards Lifesciences position peaked at $3.05M in Q4 2017.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.